PL2766008T3 - Kompozycja do podawania donosowego o ulepszonej stabilności - Google Patents

Kompozycja do podawania donosowego o ulepszonej stabilności

Info

Publication number
PL2766008T3
PL2766008T3 PL12766592T PL12766592T PL2766008T3 PL 2766008 T3 PL2766008 T3 PL 2766008T3 PL 12766592 T PL12766592 T PL 12766592T PL 12766592 T PL12766592 T PL 12766592T PL 2766008 T3 PL2766008 T3 PL 2766008T3
Authority
PL
Poland
Prior art keywords
compositions
improved stability
nasal application
nasal
application
Prior art date
Application number
PL12766592T
Other languages
English (en)
Inventor
Harald Greve
Original Assignee
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47665594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2766008(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh filed Critical Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh
Publication of PL2766008T3 publication Critical patent/PL2766008T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
PL12766592T 2011-12-30 2012-09-25 Kompozycja do podawania donosowego o ulepszonej stabilności PL2766008T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011122588 2011-12-30
DE102012005452A DE102012005452A1 (de) 2011-12-30 2012-03-20 Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
EP12766592.5A EP2766008B1 (de) 2011-12-30 2012-09-25 Zusammensetzung für die nasale applikation mit verbesserter stabilität

Publications (1)

Publication Number Publication Date
PL2766008T3 true PL2766008T3 (pl) 2017-05-31

Family

ID=47665594

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12766592T PL2766008T3 (pl) 2011-12-30 2012-09-25 Kompozycja do podawania donosowego o ulepszonej stabilności

Country Status (9)

Country Link
EP (2) EP2818163A1 (pl)
DE (2) DE202012002792U1 (pl)
DK (1) DK2766008T3 (pl)
EA (1) EA024618B1 (pl)
ES (1) ES2612652T3 (pl)
GE (1) GEP201706609B (pl)
PL (1) PL2766008T3 (pl)
UA (1) UA113749C2 (pl)
WO (1) WO2013097911A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202012005650U1 (de) 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis
DE202014105553U1 (de) * 2014-08-18 2015-08-20 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige Zusammensetzung für die nasale Applikation
DE102017117987A1 (de) * 2017-07-31 2019-01-31 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
WO2019125330A2 (en) * 2017-08-10 2019-06-27 Eli̇xi̇r İlaç Araştirma Ve Geli̇şti̇rme A.Ş. Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
WO2023046590A1 (en) * 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346886A (en) 1993-11-15 1994-09-13 John Lezdey Topical α-1-antitrypsin, non-aqueous lipid miscible, benzalkonium chloride compositions for treating skin
DE19549421C2 (de) 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19541919C2 (de) 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE10000612A1 (de) * 2000-01-10 2001-07-19 Min Becker Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel
DE10337186A1 (de) 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
DE10356248A1 (de) 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
JP2008546634A (ja) 2005-03-16 2008-12-25 ハネウェル・インターナショナル・インコーポレーテッド 医薬送達製剤、デバイス及び方法
DE102008036725B4 (de) 2008-08-07 2021-01-28 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung für die nasale Applikation
CN101756964A (zh) 2008-11-20 2010-06-30 北京利乐生制药科技有限公司 一种含有盐酸赛洛唑啉的复方药用鼻腔喷雾剂
JP2012521412A (ja) 2009-03-23 2012-09-13 ライラ ファーマシューティカルズ ピーブイティ．エルティディ． 鼻のアレルギー疾患において適用するためのクルクミノイドおよびその代謝物

Also Published As

Publication number Publication date
DE202012002792U1 (de) 2013-01-03
EP2766008B1 (de) 2016-11-02
GEP201706609B (en) 2017-01-25
EP2766008A1 (de) 2014-08-20
DK2766008T3 (en) 2017-02-13
EA024618B1 (ru) 2016-10-31
EP2818163A1 (de) 2014-12-31
ES2612652T3 (es) 2017-05-18
WO2013097911A1 (de) 2013-07-04
EA201491300A1 (ru) 2014-10-30
UA113749C2 (xx) 2017-03-10
DE102012005452A1 (de) 2013-07-04

Similar Documents

Publication Publication Date Title
GB201121070D0 (en) composition for delivery of biotherapeutics
EP2709972A4 (en) NON-FLAMMABLE COMPOSITIONS OF CHLOROTRIFLUOROPROPENE
IL230010B (en) Inhalable pharmaceutical ingredients
EP2680848A4 (en) STABLE TETRAHYDROBIOPTERINE COMPOSITIONS
SG11201400580VA (en) Pharmaceutical composition for inhalation
AP2014007498A0 (en) Pharmaceutical compositions
EP2917314A4 (en) OLIGOMERATZUSAMMENSETZUNG
EP2694076A4 (en) NASAL FORMULATIONS FROM BENZODIAZEPINE
PT2768864T (pt) Composições com concentrações aumentadas de carboximetilcelulose
HRP20180567T1 (hr) Farmaceutski pripravak omeprazola
PL2766008T3 (pl) Kompozycja do podawania donosowego o ulepszonej stabilności
HK1203355A1 (en) Uses of 4-desferrithiocin analogs 4-
EP2766829A4 (en) PROACTIVE DISTRIBUTION OF RELATED TASKS FOR IDENTIFIED ENTITIES
EP2774615A4 (en) AGENT FOR INCREASING THE QUANTITY OF MUSCLES
ZA201303024B (en) Nasal compositions of vitamin b12
EP2867199A4 (en) STABLE COMPOSITIONS OF ESOTRERODINE
ZA201402165B (en) Compositions of lopinavir
ZA201402166B (en) Compositions of efavirenz
EP2768481A4 (en) COMPOSITIONS TO REDUCE SIDE EFFECTS
EP2680843A4 (en) DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
GB201111094D0 (en) Delivery of volatile components
HK1200342A1 (zh) 鼻腔配方
EP2782902A4 (en) DERIVATIVES FROM PHENOXYISOBUTTERIC ACID
SG11201505178VA (en) Composition for nasal application